Doctor profile · Federal record

Dr. Richard Meyerholz, M.D.

Rheumatology Physician (CMS: Rheumatology) · Internal Medicine Physician · Internal Medicine Physician · Pensacola, FL

  • NPI 1144512971
  • Accepts Medicare
  • MIPS 68.1 / 100 · 2023
  • 15 yrs in practice
  • Male
  • Solo practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
8333 N Davis Hwy
Pensacola, FL 325146050
(850) 474-8387
fax (850) 969-2891

Credentials & registration

NPPES · NUCC
NPI registered
May 2011 — 15 yrs on file
Profile last updated
July 1, 2016
Year of graduation
2011 — 15 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State licenses (2)
Florida #ME126452 · Florida #TRN15931

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1144512971. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
64,905
Distinct HCPCS
10
Medicare allowed
$1,642,817
HCPCS Description Services Patients Avg allowed
J1602 Injection, golimumab, 1 mg, for intravenous use 29,675 34 $13
J0897 Injection, denosumab, 1 mg 15,300 148 $23
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 12,825 19 $42
J1745 Injection, infliximab, excludes biosimilar, 10 mg 3,740 19 $33
99213 Established patient office or other outpatient visit, 20-29 minutes 672 443 $89
99214 Established patient office or other outpatient visit, 30-39 minutes 630 289 $125
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 376 84 $61
96372 Injection of drug or substance under skin or into muscle 320 165 $14
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 248 35 $1
96413 Administration of chemotherapy into vein, 1 hour or less 207 44 $123

In context: peer comparison

Among 6 peers in Pensacola Rheumatology Physician, average services per provider: 4,300. This provider delivers 15× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,329
Transactions
100
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Novartis Pharmaceuticals Corporation 20 $411.27
GlaxoSmithKline, LLC. 11 $324.32
Abbvie INC. 14 $298.75
Amgen INC. 12 $210.58
Janssen Biotech, INC. 7 $159.78
Pfizer INC. 6 $115.07
Ucb, INC. 5 $94.56
Aurinia Pharma U.S., INC. 3 $85.05
Boehringer Ingelheim Pharmaceuticals, INC. 4 $79.11
Lilly USA, LLC 4 $76.68
Mallinckrodt Hospital Products INC. 3 $64.25
Genzyme Corporation 3 $62.52
AstraZeneca Pharmaceuticals Lp 3 $61.27
Octapharma USA, INC. 3 $58.43
Kiniksa Pharmaceuticals International, Plc 2 $43.63

By nature of payment

Food and Beverage
$2,329

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,551
Patients
548
Total drug cost
$61,910
Drug Type Claims Patients Total cost
Methotrexate (Methotrexate Sodium) Brand 274 84 $14,720
Prednisone Generic 227 84 $2,697
Hydroxychloroquine Sulfate Generic 189 65 $20,066
Tramadol Hcl Generic 142 38 $1,643
Pregabalin Generic 110 52 $3,777
Duloxetine Hcl Generic 107 30 $3,381
Gabapentin Generic 91 27 $3,035
Celecoxib Generic 88 38 $5,545
Allopurinol Generic 59 21 $1,180
Tizanidine Hcl Generic 52 16 $1,162

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Richard Meyerholz's medical specialty?
Dr. Richard Meyerholz practices Rheumatology Physician in Pensacola, FL.
Where does Dr. Richard Meyerholz practice?
Dr. Richard Meyerholz practices at 8333 N Davis Hwy, Pensacola, FL 325146050. Office phone: 8504748387.
What is Dr. Richard Meyerholz's NPI?
Dr. Richard Meyerholz's National Provider Identifier (NPI) is 1144512971, issued by NPPES.
Does Dr. Richard Meyerholz accept Medicare assignment?
Yes. Dr. Richard Meyerholz accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Richard Meyerholz commonly perform?
Top Medicare-reported procedures in 2023: Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, denosumab, 1 mg (HCPCS J0897); Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129). Source: CMS Medicare Physician & Other Practitioners file.